Prevalence and therapeutic significance of anti-interferon antibodies in hepatitis C virus/HIV-co-infected patients.
Ramos
Belen
B
Sheldon
Julie
J
Ruiz-Sancho
Andres
A
Toro
Carlos
C
Ríos
Pilar
P
Soriano
Vincent
V
D000328:Adult; D000917:Antibody Formation; D000998:Antiviral Agents / Q000276:immunology; D005260:Female; D015658:HIV Infections / Q000150:complications*; D019698:Hepatitis C, Chronic / Q000150:complications*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D017211:Treatment Failure
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b